Bicara grants new CCO option for 282,240 shares at $22.58 each
PUBT · 05/13 12:32
Share
Listen to the news
- Bicara Therapeutics granted Chief Commercial Officer Christopher Sarchi a non-qualified stock option for 282,240 shares, effective May 8, 2026.
- Exercise price set at USD 22.58 per share, matching Nasdaq closing price on May 8.
- Vesting set at 25% on first anniversary of start date, remaining shares in 12 equal quarterly installments, subject to continued service.
- Award made under Bicara 2026 Inducement Plan, adopted by board in January 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605130830PRIMZONEFULLFEED9718719) on May 13, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending